There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.
And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
View all episodes
By Audacy
3.8
261261 ratings
There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.
And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
38,137 Listeners
1,350 Listeners
1,698 Listeners
703 Listeners
960 Listeners
1,141 Listeners
737 Listeners
1,022 Listeners
321 Listeners
25,779 Listeners
1,526 Listeners
111,214 Listeners
55,983 Listeners
1,086 Listeners
10,064 Listeners
709 Listeners
6,719 Listeners
5,429 Listeners
15,932 Listeners
6,234 Listeners
5,944 Listeners
92 Listeners
15,114 Listeners
403 Listeners
1,436 Listeners